• Publications
  • Influence
The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening
There is a clear need for brief, but sensitive and specific, cognitive screening instruments as evidenced by the popularity of the Addenbrooke's Cognitive Examination (ACE).
  • 1,461
  • 168
  • PDF
Validation of the Addenbrooke's Cognitive Examination III in Frontotemporal Dementia and Alzheimer's Disease
Background/Aims: The aims of this study were to validate the newly developed version of the Addenbrooke's Cognitive Examination (ACE-III) against standardised neuropsychological tests and itsExpand
  • 448
  • 56
Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management
Patients with behavioural-variant frontotemporal dementia (bvFTD) present with insidious changes in personality and interpersonal conduct that indicate progressive disintegration of the neuralExpand
  • 382
  • 22
  • PDF
Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
Abstract This article presents the revised consensus criteria for the diagnosis of frontotemporal dysfunction in amyotrophic lateral sclerosis (ALS) based on an international research workshop onExpand
  • 271
  • 21
  • PDF
The Mini-Addenbrooke's Cognitive Examination: A New Assessment Tool for Dementia
Background/Aims: We developed and validated the Mini-Addenbrooke's Cognitive Examination (M-ACE) in dementia patients. Comparisons were also made with the Mini Mental State Examination (MMSE).Expand
  • 139
  • 14
  • PDF
Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum
There is increasing evidence that amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) lie on a clinical, pathological and genetic continuum with patients of one disease exhibitingExpand
  • 155
  • 13
  • PDF
Pharmacological Management of Lewy Body Dementia: A Systematic Review and Meta-Analysis.
OBJECTIVE The authors examined research on effects, costs, and patient and caregiver views of pharmacological management strategies for Lewy body dementia. METHOD Studies were identified throughExpand
  • 129
  • 13
  • PDF
Clinical staging and disease progression in frontotemporal dementia
Objective: We aimed to develop a novel tool capable of staging disease severity in frontotemporal dementia (FTD) based upon functional dependence and behavioral changes, and to assess change overExpand
  • 228
  • 10
  • PDF
Activities of daily living in frontotemporal dementia and Alzheimer disease
Objective: To evaluate activities of daily living (ADLs) in three clinical variants of frontotemporal dementia and the relationship to cognitive dysfunction. Methods: Fifty-nine patients andExpand
  • 167
  • 9
Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum
Abstract Our objective was to compare the cognitive and behavioural profile of patients with amyotrophic lateral sclerosis (ALS) and behavioural variant frontotemporal dementia (bvFTD), and toExpand
  • 119
  • 8